Abbott and the Abbott Fund are supporting the vital work of the African Federation for Emergency Medicine (AFEM) to reach 2,000 emergency care professionals who are on the front lines in 26 African countries. AFEM is using technology to broadly reach, educate and share solutions on COVID-19 care with these emergency experts — who will in turn share their knowledge with other healthcare providers operating in their local countries.
Through a grant to AFEM, Abbott is sponsoring a series of virtual training webinars scheduled weekly from April through November in multiple languages. Local specialists, WHO representatives, frontline providers and health leaders are volunteering their time to support the training, with Abbott employees providing technical support to host and coordinate the webinars.
Direct Relief announced $5 million in grants to expand testing, triage and treatment in diverse, underserved communities disproportionately affected and at greater risk from the virus. The funding from Direct Relief will be provided through the Direct Relief + Abbott Fund COVID-19 Community Grant Program, made possible by a donation from the Abbott Fund, the foundation of the global healthcare company Abbott. The grants will support 25 federally qualified health centers in California, Florida, Illinois, Massachusetts, New Jersey and New York. The program helps health centers to strengthen their capabilities to safely and effectively screen, test, triage and treat COVID-19 cases and provide clinical education to patients in the communities they serve.
To help families with the greatest need have access to formula, Abbott is donating Similac® infant formula—a total of 1.5 million feedings— to seven Feeding America food banks across the nation experiencing the greatest need. Through this donation and our broader work to provide access to our products, Abbott is delivering on its promise to help parents nourish their babies.
The ID NOW rapid test is used in urgent care settings where people need results fast. The test shows results in as little as 13 minutes, helping to identify SARS-CoV-2 before it spreads. Abbott has shipped 1.8 million tests for COVID-19 and 15 complaints have been reported to FDA in real-world situations. The test is in use in 1,000+ locations across the U.S. A new study by a leading COVID-19 researcher found 91% sensitivity with 100% specificity.
To help meet the needs of patients and healthcare providers affected by the coronavirus outbreak in China, Abbott donated diagnostics, nutrition products and funding. Donations include the ARCHITECT c8000 clinical chemistry system, which runs high-volume diagnostic tests to monitor patient health; the i-STAT handheld blood analyzer system, which provides healthcare workers with fast diagnostic test results to monitor patient health by their bedside; Ensure Complete, PediaSure, Pedialyte and other Abbott nutrition products for patients and medical professionals; and funding for the purchase of medical necessities including protective suits, masks and disinfectant.